首页> 外文期刊>Behavioral Medicine >Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
【24h】

Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.

机译:喹硫平成功治疗患有难治性分裂情感障碍的攻击性患者。

获取原文
获取原文并翻译 | 示例
           

摘要

The author relates the case study of a 38-year-old man with schizoaffective disorder (bipolar type) refractory to multiple medications. This patient had a long history of psychiatric illness and had been hospitalized at least 15 times because of aggression, hostility, and psychosis. Two separate trials of risperidone and olanzapine resulted in adverse effects, including possible neuroleptic malignant syndrome. Quetiapine, as part of combination therapy, led to substantial reductions in the patient's schizoaffective disorder symptoms and problematic behaviors. The patient tolerated quetiapine and did not experience any adverse effects. Quetiapine may be a suitable treatment option in patients with schizoaffective disorder.
机译:作者将一名难治性分裂情感障碍(双相型)的38岁男子的病例研究与多种药物相关联。该患者有悠久的精神病史,并且由于侵略,敌对和精神病而住院至少15次。利培酮和奥氮平的两项独立试验导致不良反应,包括可能的精神安定性恶性综合征。喹硫平作为联合疗法的一部分,导致患者的精神分裂情感障碍症状和有问题的行为大大减少。患者耐受喹硫平并且没有经历任何不良反应。喹硫平可能是分裂情感障碍患者的合适治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号